Sara Ricardo

Porto, 4200135, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Anti-PD-1 Treatment Restores Effector Function in Exhausted-like T Cells from Malignant Ascites of Ovarian Cancer Patients.

Anti-PD-1 Treatment Restores Effector Function in Exhausted-like T Cells from Malignant Ascites of Ovarian Cancer Patients.

Journal: Cancers

Published: June 22, 2026

Re-Thinking Pharmacokinetics in Ovarian Cancer: What Do Organoids Add?

Re-Thinking Pharmacokinetics in Ovarian Cancer: What Do Organoids Add?

Journal: International journal of molecular sciences

Published: March 10, 2026

A clinical-stage oncology compound selectively targets drug-resistant cancers.

A clinical-stage oncology compound selectively targets drug-resistant cancers.

Journal: bioRxiv : the preprint server for biology

Published: December 15, 2025

Tracking Chemotherapy Effects via ALDH1A1, SOX2, CD44v6, and P-gp Expression in Malignant Ascites from High-Grade Serous Carcinoma.

Tracking Chemotherapy Effects via ALDH1A1, SOX2, CD44v6, and P-gp Expression in Malignant Ascites from High-Grade Serous Carcinoma.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: November 18, 2025

Galanthamine Fails to Reverse P-gp-Mediated Paclitaxel Resistance in Ovarian Cancer Cell Lines.

Galanthamine Fails to Reverse P-gp-Mediated Paclitaxel Resistance in Ovarian Cancer Cell Lines.

Journal: Biomedicines

Published: October 27, 2025

Paclitaxel resistance-associated metabolic events in ovarian cancer cells.

Paclitaxel resistance-associated metabolic events in ovarian cancer cells.

Journal: Metabolomics : Official journal of the Metabolomic Society

Published: July 07, 2025

P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma.

P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma.

Journal: Virchows Archiv : an international journal of pathology

Published: February 13, 2025

A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer.

A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 27, 2024

Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures.

Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 24, 2024

Metformin Impairs Linsitinib Anti-Tumor Effect on Ovarian Cancer Cell Lines.

Metformin Impairs Linsitinib Anti-Tumor Effect on Ovarian Cancer Cell Lines.

Journal: International journal of molecular sciences

Published: October 16, 2024

Antioxidant treatment attenuates age-related placenta GLUT-1 and PLIN-2 downregulation.

Antioxidant treatment attenuates age-related placenta GLUT-1 and PLIN-2 downregulation.

Journal: Placenta

Published: July 03, 2024

Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options.

Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options.

Journal: Cells

Published: April 19, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026